2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee

  • Antoine Verger
  • , Henryk Barthel
  • , Nelleke Tolboom
  • , Francesco Fraioli
  • , Diego Cecchin
  • , Nathalie L. Albert
  • , Bart van Berckel
  • , Ronald Boellaard
  • , Matthias Brendel
  • , Ozgul Ekmekcioglu
  • , Franck Semah
  • , Tatjana Traub-Weidinger
  • , Donatienne van de Weehaeghe
  • , Silvia Morbelli
  • , Eric Guedj*
  • *Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)3599-3606
Number of pages8
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume49
Issue number11
DOIs
Publication statusPublished - Sept 2022

Keywords

  • Brain/diagnostic imaging
  • COVID-19/complications
  • Fluorodeoxyglucose F18
  • Humans
  • Neuroimaging
  • Positron-Emission Tomography/methods
  • Radiopharmaceuticals
  • Post-Acute COVID-19 Syndrome

Cite this